Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 15Neoplasm Metastasis 3Neoplasms 2Triple Negative Breast Neoplasms 1Thrombocytosis 1Solid Tumours 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metastatic Castration-Resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 3blinatumomab 2enzalutamide 1durvalumab 1dostarlimab 1cemiplimab 1atezolizumab 1abiraterone 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Immune Checkpoint Inhibitors 1Hydroxyurea 1Etoposide 1Etanercept 1Cytochrome P-450 Enzyme System 1Carboplatin 1AMG 757 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Bites and Stings × abiraterone × Clear all
NCT04221542 2026-05-29

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Amgen

Phase 1 Recruiting
479 enrolled
Genitourinary

Bites and Stings, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡